<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05624619</url>
  </required_header>
  <id_info>
    <org_study_id>STI-01</org_study_id>
    <nct_id>NCT05624619</nct_id>
  </id_info>
  <brief_title>The Diagnostic and Prognostic Value of Speckle Tracking Imaging in Septic Cardiomyopathy</brief_title>
  <official_title>The Diagnostic and Prognostic Value of Speckle Tracking Imaging in Septic Cardiomyopathy: a Prospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Zhongshan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Zhongshan Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to explore if STI technology, especially TMAD, plays an important&#xD;
      role in evaluating left ventricular longitudinal systolic function and discriminating SICM in&#xD;
      patients with sepsis. We also intend to prove that TMAD may have predictive value in patients&#xD;
      with sepsis, which is worthy of in-depth study to find strong evidence-based medical evidence&#xD;
      for subsequent clinical practical applications.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 18, 2022</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>28-day mortality</measure>
    <time_frame>28 days</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Sepsis-induced Cardiomyopathy</condition>
  <condition>Speckle Tracking Imagining</condition>
  <condition>Tissue Motion Annular Displacement</condition>
  <eligibility>
    <study_pop>
      <textblock>
        adult patients who are diagnosed as sepsis according to sepsis 3.0 criteria, excluding&#xD;
        those with history of organic heart disease, heart failure, atrial fibrillation or holder&#xD;
        of cardiac implanted device&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients who are diagnosed as sepsis according to sepsis 3.0 criteria&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients with history of organic heart disease;&#xD;
&#xD;
          -  patients with history of heart failure&#xD;
&#xD;
          -  holder of cardiac implanted device;&#xD;
&#xD;
          -  patients with history of atrial fibrillation;&#xD;
&#xD;
          -  refusal to participate in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 14, 2022</study_first_submitted>
  <study_first_submitted_qc>November 14, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 22, 2022</study_first_posted>
  <last_update_submitted>November 14, 2022</last_update_submitted>
  <last_update_submitted_qc>November 14, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 22, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiomyopathies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

